What is the ideal serum beta‑human chorionic gonadotropin level on day 14 after a fresh cleavage‑stage (3‑day) embryo transfer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ideal β-hCG Level on Day 14 After 3-Day Fresh Embryo Transfer

For a 3-day fresh cleavage-stage embryo transfer, a serum β-hCG level ≥100 IU/L on day 14 post-transfer predicts an ongoing pregnancy with high sensitivity, while levels ≥200 mIU/ml are associated with an 80% ongoing pregnancy rate, and levels >600 mIU/ml strongly suggest multiple gestation. 1, 2

Evidence-Based β-hCG Thresholds for Day 14 Post-Transfer

Single Cleavage Embryo Transfer

  • Threshold for clinical pregnancy prediction: ≥100 IU/L on day 16 after oocyte retrieval (equivalent to day 13 post-transfer for day-3 embryos) 2
  • This threshold was derived from multivariable regression analysis specifically for single fresh cleavage embryo transfers 2
  • Mean β-hCG levels for successful single cleavage transfers range from 245 ± 204 IU/L to 314.5 ± 36.9 IU/L when measured 12-16 days post-oocyte retrieval 2, 3

Multiple Embryo Transfer Outcomes

When multiple cleavage-stage embryos are transferred, the β-hCG stratification on day 14 post-transfer predicts outcomes as follows:

  • <200 mIU/ml: Lower ongoing pregnancy rates; 19.8% spontaneous miscarriage rate overall 1
  • 200-300 mIU/ml: Moderate ongoing pregnancy rate; 9% multiple pregnancy rate 1
  • 300-600 mIU/ml: 40% ongoing multiple pregnancy rate 1
  • >600 mIU/ml: 100% multiple gestation rate in ongoing pregnancies 1

Clinical Application Algorithm

Step 1: Obtain Baseline β-hCG

  • Measure serum quantitative β-hCG exactly 14 days after embryo transfer (or day 16-17 post-oocyte retrieval for day-3 transfers) 1, 4
  • Timing is critical because β-hCG values are not affected by the day of embryo transfer when measured at equivalent intervals post-oocyte retrieval 4

Step 2: Interpret Initial Value

β-hCG Level (mIU/ml) Interpretation Recommended Action
<42 56.4% abnormal outcome risk (miscarriage/ectopic) Serial β-hCG in 48 hours; early ultrasound at 5-6 weeks [5]
42-100 Intermediate risk Serial β-hCG monitoring; ultrasound at 6 weeks [5,2]
100-200 Likely viable pregnancy Routine ultrasound at 6-7 weeks [2]
200-300 High probability ongoing pregnancy Routine prenatal care; ultrasound at 6-7 weeks [1]
300-600 40% multiple gestation risk Early ultrasound at 5-6 weeks to assess number of sacs [1]
>600 100% multiple gestation Immediate ultrasound; counsel on multiple pregnancy risks [1]

Step 3: Serial Monitoring for Suboptimal Values

  • If initial β-hCG is <100 IU/L, obtain repeat measurement 48-72 hours later to assess doubling pattern 5
  • Normal viable pregnancies show ≥53-66% rise over 48 hours in early gestation 6
  • Abnormal rise patterns (<53% increase) or plateauing suggest nonviable pregnancy or ectopic gestation 6

Step 4: Ultrasound Correlation

  • Schedule transvaginal ultrasound at 5-6 weeks gestational age (3 weeks post-transfer) for all positive β-hCG results 1
  • For β-hCG >300 mIU/ml, perform earlier ultrasound to identify multiple gestations and counsel appropriately 1
  • Document presence of gestational sac, yolk sac, embryo, and cardiac activity 7

Important Clinical Considerations

Distinguishing Normal from Abnormal Pregnancies

  • Mean β-hCG for normal pregnancies: 91 ± 85.8 mIU/ml (measured days 11-12 post-transfer) 5
  • Mean β-hCG for abnormal pregnancies: 29 ± 24.9 mIU/ml (measured days 11-12 post-transfer) 5
  • The 42 mIU/ml cutoff yields 79.3% sensitivity and 83.8% specificity for predicting normal pregnancy outcome 5

Embryo Stage Does Not Affect Timing-Adjusted Values

  • When measured at equivalent time points post-oocyte retrieval, β-hCG levels are not significantly different between day-3 and day-5 transfers (median 297 IU/L for both groups on day 17 post-retrieval) 4
  • This means the same thresholds apply whether measuring from transfer date or oocyte retrieval date, as long as timing is consistent 4

Blastocyst Transfer Comparison

  • If comparing to blastocyst transfers, note that blastocyst transfers yield higher β-hCG values (299 ± 204 IU/L vs 245 ± 204 IU/L for cleavage) when measured at the same post-retrieval timepoint 2
  • The threshold for blastocyst transfers is 133 IU/L rather than 100 IU/L 2

Critical Pitfalls to Avoid

  • Never rely on a single β-hCG value alone to diagnose pregnancy failure; serial measurements and ultrasound correlation are mandatory 6
  • Do not use β-hCG thresholds to exclude ectopic pregnancy; approximately 22% of ectopic pregnancies occur with β-hCG <1,000 mIU/mL 6
  • Avoid premature diagnosis of multiple gestation based solely on β-hCG; ultrasound confirmation is required 1
  • Do not defer ultrasound in patients with β-hCG >600 mIU/ml, as these patients require early assessment for multiple gestation and appropriate counseling on associated risks 1
  • Remember that β-hCG values have wide individual variation; a single value below the mean does not necessarily indicate poor prognosis if serial values show appropriate rise 5, 2

References

Research

Predictive value of hCG level 14 days after embryo transfer.

Journal of assisted reproduction and genetics, 1995

Research

What is the effect of embryo morphology on serum β-hCG levels?

European journal of obstetrics, gynecology, and reproductive biology, 2019

Research

Embryo transfer day does not affect the initial maternal serum β-hCG levels: A retrospective cohort study.

European journal of obstetrics, gynecology, and reproductive biology, 2017

Guideline

hCG and Progesterone Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the significance of a high initial beta human chorionic gonadotropin (hCG) level of 8000 after a single embryo transfer?
What are the next steps after a serum beta-human chorionic gonadotropin (BHCG) level of 204 milli-international units per milliliter (mIU/mL) on day 12 of blastocyst transfer, following an intramuscular (IM) injection of 5000 international units (IU) of human chorionic gonadotropin (hCG) 3 days prior?
What is the frequency of false‑negative serum beta‑human chorionic gonadotropin results after a fresh three‑day cleavage‑stage embryo transfer when measured at the standard 14‑day post‑transfer time point?
If my serum quantitative beta‑human chorionic gonadotropin level is less than 5 mIU/mL at 12 days after the luteinizing hormone surge, does that accurately indicate I am not pregnant this cycle?
What are the implications of a beta-human chorionic gonadotropin (beta-hCG) level of 200 milli-international units (mIU) on day 12 post embryo transfer in a patient with a history of significantly diminished ovarian reserve and previous failed pregnancy?
Does daratumumab (Darzalex) treat multiple myeloma?
I started fluoxetine (Prozac) 4 weeks ago and now have increased anxiety; what should I do?
In an adult with mild hypocalcemia (serum calcium 7.5–8.0 mg/dL) and normal renal function, how soon does parathyroid hormone decrease after an aggressive calcium infusion?
What is the first‑line inotrope for a patient with acute stroke who develops hypotension or low cerebral perfusion?
How do proton-pump inhibitors and H2-receptor antagonists affect bone health?
Can neuropathy associated with Waldenström macroglobulinemia be reversed with treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.